Myriad Genetics Inc (MYGN)

Net profit margin

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net income	US$ in thousands	-127,300	-263,300	-112,000	-27,200	-223,700
Revenue	US$ in thousands	837,600	753,200	678,400	690,600	557,000
Net profit margin		-15.20%	-34.96%	-16.51%	-3.94%	-40.16%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $-127,300K ÷ $837,600K
= -15.20%

The net profit margin of Myriad Genetics Inc over the past five years has exhibited a downward trend, starting at a significant negative figure of -40.16% as of December 31, 2020, and gradually improving to -3.94% by December 31, 2021. However, the margin deteriorated again to -16.51% by December 31, 2022, before worsening further to -34.96% by December 31, 2023. Nevertheless, there was a slight recovery observed by December 31, 2024, with the net profit margin improving to -15.20%. Overall, the company has faced challenges in generating profits relative to its revenue over the period under review.